Standout Papers

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of ... 2017 2026 2020 2023 1.6k
  1. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy (2017)
    Amira Barkal, Kipp Weiskopf et al. Nature Immunology
  2. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity (2017)
    Sydney Gordon, Roy L. Maute et al. Nature

Immediate Impact

9 by Nobel laureates 9 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
2 intermediate papers

Works of Roy L. Maute being referenced

CD47–SIRPα-targeted therapeutics: status and prospects
2022
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature

Author Peers

Author Last Decade Papers Cites
Roy L. Maute 1852 1432 1252 20 3.4k
Oakley C. Olson 2219 1445 1290 22 4.1k
Julie S. Lau 1686 1725 1140 25 3.5k
Ferenc A. Scheeren 1464 1155 1386 47 3.3k
Jonathan M. Tsai 1677 1289 1040 25 3.1k
Yoko Oei 1908 1071 1321 17 3.5k
Riccardo Mezzadra 1469 1881 1069 14 3.1k
Farbod Shojaei 1328 1453 2362 35 4.0k
José Luís Barrera 1996 3290 1456 32 4.5k
Sandrine Valsesia‐Wittmann 771 1498 1331 24 2.7k
Viviana Cremasco 1410 1551 1159 30 3.2k

All Works

Loading papers...

Rankless by CCL
2026